4.5 Review

Eph receptors in breast cancer: roles in tumor promotion and tumor suppression

Journal

BREAST CANCER RESEARCH
Volume 10, Issue 6, Pages -

Publisher

BIOMED CENTRAL LTD
DOI: 10.1186/bcr2207

Keywords

-

Categories

Funding

  1. NIH [CA95004, CA114301, CA1179151]
  2. US Department of Defense [W81XWH-08-1-0249]
  3. NATIONAL CANCER INSTITUTE [R01CA095004, R01CA114301] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Eph receptor tyrosine kinase signaling regulates cancer initiation and metastatic progression through multiple mechanisms. Studies of tumor-cell-autonomous effects of Eph receptors demonstrate their dual roles in tumor suppression and tumor promotion. In addition, Eph molecules function in the tumor microenvironment, such as in vascular endothelial cells, influencing the ability of these molecules to promote carcinoma progression and metastasis. The complex nature of Eph receptor signaling and crosstalk with other receptor tyrosine kinases presents a unique challenge and an opportunity to develop therapeutic intervention strategies for targeting breast cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available